0000899243-16-026413.txt : 20160805 0000899243-16-026413.hdr.sgml : 20160805 20160805160547 ACCESSION NUMBER: 0000899243-16-026413 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150807 FILED AS OF DATE: 20160805 DATE AS OF CHANGE: 20160805 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Prothena Corp plc CENTRAL INDEX KEY: 0001559053 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25-28 NORTH WALL QUAY CITY: DUBLIN STATE: L2 ZIP: DUBLIN 1 BUSINESS PHONE: 650-615-2119 MAIL ADDRESS: STREET 1: 25-28 NORTH WALL QUAY CITY: DUBLIN STATE: L2 ZIP: DUBLIN 1 FORMER COMPANY: FORMER CONFORMED NAME: Neotope Corp Ltd DATE OF NAME CHANGE: 20120926 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HENNEY CHRISTOPHER S CENTRAL INDEX KEY: 0001242880 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35676 FILM NUMBER: 161811181 MAIL ADDRESS: STREET 1: 10505 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2015-08-07 2015-08-07 0 0001559053 Prothena Corp plc PRTA 0001242880 HENNEY CHRISTOPHER S C/O PROTHENA BIOSCIENCES INC 650 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Ordinary Shares, par value $0.01 per share 2015-08-07 4 M 0 10000 6.65 A 10000 D Ordinary Shares, par value $0.01 per share 2015-08-07 4 S 0 4400 62.3356 D 5600 D Ordinary Shares, par value $0.01 per share 2015-08-07 4 S 0 4560 63.2523 D 1040 D Ordinary Shares, par value $0.01 per share 2015-08-07 4 S 0 1040 64.0301 D 0 D Stock Option (right to buy) 6.65 2015-08-07 4 M 0 10000 0.00 D 2023-03-18 Ordinary Shares 10000 40000 D The transaction was executed in multiple trades in prices ranging from $61.785 to $62.785, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. The transaction was executed in multiple trades in prices ranging from $62.80 to $63.785, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. The transaction was executed in multiple trades in prices ranging from $63.84 to $64.16, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. The shares subject to the option are fully vested and exercisable as of the date hereof. In the original Form 4 filed on August 7, 2015, due to an administrative error, the purchase price in column four of row one of Table I was incorrectly listed as $6.41, rather than the correct purchase price of $6.65. This amendment is filed to correct the Form 4 to report the acquisition price of $6.65 per share under the reported transaction. /s/ A.W. Homan, as Attorney-in-Fact for Christopher S. Henney 2016-08-05